Teleflex has acquired substantially all of the BIOTRONIK Vascular Intervention business, effective July 1, 2025.
As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people's lives. Through our vision to become the most trusted partner in the world of healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare. Teleflex is the home of Arrow, Barrigel, Deknatel, LMA, Pilling, QuikClot, Rusch, UroLift and Weck - trusted brands united by a common sense of purpose.
At Teleflex, we are empowering the future of healthcare. For more information, please visit teleflex.com
The headquarters of the Vascular Intervention business unit, located in Bulach, Switzerland, is responsible for the development, production and marketing of balloon catheters and drug-coated stent systems.
MNCJobs.ch will not be responsible for any payment made to a third-party. All Terms of Use are applicable.